Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Detection and Prediction of Cardiotoxicity in Radiotherapy-treated Breast Cancer Patients

NCT02605512 is registered in ClinicalTrials.gov with Sophie JACOB as lead sponsor.

NCT NCT02605512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02605512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Detection and Prediction of Cardiotoxicity in Radiotherapy-treated Breast Cancer Patients
Lead sponsor
Sophie JACOB
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2015
Completion date
February 29, 2020
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cardiac toxicity